Concord Biotech consolidated net profit declines 2.13% in the December 2024 quarter
Sales rise 1.42% to Rs 244.22 crore
Net profit of Concord Biotech declined 2.13% to Rs 75.92 crore in the quarter ended December 2024 as against Rs 77.57 crore during the previous quarter ended December 2023. Sales rose 1.42% to Rs 244.22 crore in the quarter ended December 2024 as against Rs 240.80 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var.Sales244.22240.80 1 OPM %40.1143.99 -PBDT114.42116.64 -2 PBT101.15103.10 -2 NP75.9277.57 -2Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content